Gut Liver.
2014 Jul;8(4):335-336.
Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. DYK1025@yuhs.ac
Abstract
- No abstract available.
MeSH Terms
-
Antiviral Agents/*administration & dosage
Female
Hepatitis C, Chronic/*drug therapy
Humans
Interferon-alpha/*administration & dosage
Male
Polyethylene Glycols/*administration & dosage
Recombinant Proteins/administration & dosage
Ribavirin/*administration & dosage
Antiviral Agents
Interferon-alpha
Polyethylene Glycols
Recombinant Proteins
Ribavirin
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment
- A Case of Cutaneous Sarcoidosis Associated with Pegylated Interferon Alpha-2a and Ribavirin Therapy
- A Case of Vitiligo in a Hepatitis C Patient after Pegylated Interferon Treatment
- Optimizing the Dose and Duration of Therapy for ChronicHepatitis C
- Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection
